According to a recent LinkedIn post from Resilience Care, the company is drawing attention to how telemonitoring may affect the doctor‑patient relationship in radiotherapy. The post cites the perspective of Dr. Jérôme Chamois of ICRB – Institut de Cancérologie et Radiothérapie Bretillien, who reportedly observes that telemonitoring can create a stronger sense of support, reinforce connections, and enhance patient safety.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post positions this shift as a change in clinical practice that raises questions but also appears to transform care relationships. For investors, this focus suggests Resilience Care is aligned with digital health models that emphasize remote monitoring and patient engagement, which could support long‑term demand for its solutions and strengthen its positioning within technology‑enabled oncology care pathways.

